NHS England Offers ‘Improved’ Orkambi Deal, But Vertex Lukewarm

 
• By Ian Schofield

The NHS in England says it has made a “revised and improved” offer to Vertex to make Orkambi available, but the company is not impressed and says its attitude to the negotiations has been mischaracterized.

CysticFibrosis
Talks are continuing on access to Vertex's CF drug Orkambi • Source: Shutterstock

More from Health Technology Assessment

More from Market Access